Computer-aided detection gains popularity for use in screening and diagnostic mammography

Share this article:

Radiologists have increased their use of computer-aided detection (CAD) in screening and diagnostic mammography, according to a study published in the Journal of the American College of Radiology (2010 Oct;7(10):802-5).

For the study, researchers at Thomas Jefferson University Hospital reviewed codes in records from 2004 to 2008 for screening and diagnostic mammography, as well as screening and diagnostic CAD.

The results of the study revealed that in 2008, of the screening mammograms performed, 74% involved the use of CAD, compared to 39% in 2004. “By 2008, CAD was used in about three-quarters of all screening exams and half of all diagnostic exams,” said Vijay Rao, MD, lead author of the study. “The use of CAD is controversial, while some support it and others are critical of it. Nonetheless, while there remains debate over the efficacy of CAD, it is apparent that radiologists are increasingly utilizing this technology and that it is becoming standard practice in breast diagnosis." ONA

Share this article:
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs

More in Web Exclusives

Improved tyrosine kinase inhibitor (TKI) selectively activates in tumor tissue, minimizing side ...

A new strategy developed by an interdisciplinary team of researchers aims to reduce the side effects connected to use of tyrosine kinase inhibitors (TKIs).

Prior cancer exclusion criteria may stymie potential of lung cancer clinical trials

A history of prior cancer can exclude many individuals from participation in clinical trails related to lung cancer, even when the prior cancer is unlikely to interfere with treatment outcomes.

Better adherence to guidelines for safe handling of antineoplastic drugs is needed

Recommended safe handling practices for workers who administer antineoplastic drugs in health care settings are not always followed, according to a new study.